Rapid Micro Biosystems, Inc. (RPID) Stock Forecast
RPID analyst forecast
as of October 18, 2026- Analyst consensus
- Strong buy 5.00 / 5 from 5 analysts
- Price target
- $5.75 average of analyst targets
- Upside to target
- +652.6% from the latest close
- Next earnings
- November 6, 2026 EPS estimate $-0.20
- 52-week range
- $0.76 – $4.68
RPID analyst ratings
5 analystsNumber of analysts at each rating.
RPID price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
RPID earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.20 | −$0.21 | −$0.19 | −$0.26 | +22.1% | 4 |
| Current fiscal year (2026) | −$0.94 | −$0.96 | −$0.91 | −$1.05 | +10.2% | 4 |
| Next fiscal year (2027) | −$0.71 | −$0.77 | −$0.65 | −$0.94 | +24.1% | 4 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
RPID revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $9.9M | $9.4M | $10.8M | +26.1% | 5 |
| Current fiscal year (2026) | $39.3M | $38.5M | $40.7M | +17.0% | 5 |
| Next fiscal year (2027) | $46.3M | $44.0M | $49.0M | +17.9% | 5 |
RPID EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
RPID revenue: reported and forecast
RPID EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.20 | −$0.20 | −$0.20 | −$0.20 | −$0.20 | +1.2% | 1 up · 1 down |
| Current fiscal year (2026) | −$0.93 | −$0.93 | −$0.94 | −$0.94 | −$0.94 | +1.3% | 1 up · 2 down |
| Next fiscal year (2027) | −$0.79 | −$0.79 | −$0.73 | −$0.73 | −$0.71 | −9.5% | 2 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
RPID earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; RPID beat in 2 of 12.
What analysts expect from RPID
5 analysts cover Rapid Micro Biosystems; their consensus rating is strong buy (5.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $5.75, 652.6% above the latest close of $0.76. Analysts expect earnings of −$0.94 per share for 2026, +10.2% from a year earlier. For 2027 the average estimate is −$0.71 per share on revenue of $46.3 million. Rapid Micro Biosystems beat the EPS estimate in 2 of the last 12 quarters.
Related: RPID income statement, RPID key metrics, RPID chart. See the RPID stock overview for the latest quote and news.
RPID forecast FAQ
What is Rapid Micro Biosystems's price target?
The average analyst price target for Rapid Micro Biosystems is $5.75, 652.6% above the latest close of $0.76.
Is Rapid Micro Biosystems a buy, hold or sell?
Of 5 analysts covering Rapid Micro Biosystems, 5 rate it a strong buy, 0 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Rapid Micro Biosystems's EPS forecast?
Analysts forecast −$0.94 per share for 2026 (range −$0.96 to −$0.91); for 2027 the estimate is −$0.71.
What is Rapid Micro Biosystems's revenue forecast?
The average revenue estimate for 2026 is $39.3 million, growth of 17.0%; for 2027 it is $46.3 million.
When does Rapid Micro Biosystems report earnings?
Rapid Micro Biosystems is expected to report results for the quarter ending September 30, 2026 on November 6, 2026 before the market opens; the EPS estimate is $-0.20.
Does Rapid Micro Biosystems usually beat earnings estimates?
Rapid Micro Biosystems reported EPS at or above the analyst estimate in 2 of the last 12 quarters.